Article Text

Download PDFPDF

LP-091 Neutrophil extracellular traps in APS and SLE
  1. Kamila Nurbaeva1,
  2. Tatiana Reshetnyak1,
  3. Margarita Kuzina2,
  4. Irina Vasilenko2 and
  5. Aleksander Lila1
  1. 1Laboratory of Thromboinflammation, Nasonova Research Institute of Rheumatology, Russian Federation
  2. 2Laboratories of biomedical research methods, Moscow Regional Clinical Research Institute named after M.F. Vladimirsky (MONIKI), Russian Federation


Background Background: neutrophil extracellular traps (NETs) are released by activated neutrophils. It has been shown that NETs play a role in the pathogenesis of different autoimmune diseases, including systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (PAPS). The aim: evaluate levels of NETs observed in blood smears and their association with clinical variables in SLE, SLE+APS, and PAPS.

Methods The study included 54 patients with SLE (SLICC criteria, 2012), 37 with PAPS (Sydney criteria, 2006), 42 with SLE+APS, and 27 healthy controls without acute infections. NETs were investigated in standardized thin blood smears produced from citrated whole blood and stained by the Giemsa method. NETs percentage to the number of neutrophils was calculated (%NETs).

Results Neutrophils in PAPS, SLE+APS, and SLE released significantly more NETs than neutrophils in the control group (p=0.023). When comparing the groups in pairs, we found that the level of NETs% was higher in PAPS, SLE+APS, and SLE compared to controls (p<0.05). There were no significant differences between the levels of NETs among patients (p>0.05). NETs levels was not associated with SLE activity. Patients with glomerulonephritis in SLE and SLE+APS had significantly lower NETs capacity (4 [2.6; 5.6] versus 6.6 [2.6; 11.1], p=0.04). The levels of NETs did not differ significantly in patients with PAPS and SLE+APS depending on antiphospholipid (aPL) positivity (single, double, triple positivity), history of thrombosis or obstetric pathology.

Conclusions NETs levels were higher in SLE, SLE+APS, and PAPS compared to controls. SLE patients with renal involvement had significantly lower NETs levels. This study was prepared as a part of the fundamental scientific theme №1021051402790.

  • NETs
  • systemic lupus erythematosus
  • antiphospholipid syndrome

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.